1. Home
  2. RYTM vs WIX Comparison

RYTM vs WIX Comparison

Compare RYTM & WIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$88.26

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

HOLD

Current Price

$48.05

Market Cap

4.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
WIX
Founded
2008
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.7B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
RYTM
WIX
Price
$88.26
$48.05
Analyst Decision
Strong Buy
Buy
Analyst Count
14
22
Target Price
$131.14
$134.67
AVG Volume (30 Days)
491.0K
2.5M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
28.34
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$55.34
$15.80
Revenue Next Year
$86.06
$13.21
P/E Ratio
N/A
$28.86
Revenue Growth
N/A
N/A
52 Week Low
$60.71
$46.90
52 Week High
$122.20
$190.92

Technical Indicators

Market Signals
Indicator
RYTM
WIX
Relative Strength Index (RSI) 49.80 33.88
Support Level $87.19 N/A
Resistance Level $92.51 $93.82
Average True Range (ATR) 3.56 3.86
MACD -0.24 -0.14
Stochastic Oscillator 49.10 9.91

Price Performance

Historical Comparison
RYTM
WIX

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years it has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

Share on Social Networks: